Elimination of maternal antibodies against measles (is the policy of vaccinating children younger than nine months of age suitable for Turkey?) | Health & Environmental Research Online (HERO)

Health & Environmental Research Online (HERO)

Print Feedback Export to File

This record has one attached file:

Citation
Tags

HERO ID

7539151

Reference Type

Journal Article

Title

Elimination of maternal antibodies against measles (is the policy of vaccinating children younger than nine months of age suitable for Turkey?)

Author(s)

Kanra, G; Ceyhan, M

Year

1991

Is Peer Reviewed?

Journal

Turkish Journal of Pediatrics
ISSN: 0041-4301

Volume

Issue

Page Numbers

217-220

Language

English

PMID

1814038

Web of Science Id

WOS:A1991HR96800002

URL

http://://WOS:A1991HR96800002
Exit

Abstract

Maternal antibodies against measles in 223 healthy children aged 22 to 31 weeks were studied. The ratio of children with detectable antibodies declined from 61.4 percent at 22-23 weeks of age to 20 percent at 26-27 weeks of age. Since the minimum proportion of antibody-positive children (15.6% at 26-27 weeks of age) is still higher than the optimum proportion (5%), the Schwarz vaccine which is used mostly in measles immunization seems not to be effective to obtain a high seroconversion rate in our infants. We suggest that the Edmonston-Zagreb strain of measles vaccine be used for infants under 9 months of age in Turkey.